Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...

US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...

Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease: Laval, Quebec Wednesday, July 30, 2025, 1 ...

Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden: Ter Apel, Netherlands Wednesday, July 30, 2025, 13:00 Hrs [IST] ...

Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...

Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT: Our Bureau, Bengaluru Wednesday, July 30, 2025, 10:45 Hrs [IST] Strides Pharma Sc ...

Waltham, Massachusetts Wednesday, July 30, 2025, 11:00 Hrs [IST] ...

EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC: San Carlos, California Wednesday, July 30, 2025, 12:00 Hrs [IST] BeOne Medici ...

Avidity Biosciences completes enrolment in HARBOR phase 3 trial of delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Wednesday, July 30, 2025, 10:00 Hrs [IST] A ...

Peethaambaran Kunnathoor, Chennai Wednesday, July 30, 2025, 08:00 Hrs [IST] ...

Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre: Gireesh Babu, New Delhi Wednesday, July 30, 2025, 08:00 Hrs [IST] The Schemes supporting develo ...

A culture of quality excipients has ushered in as the pharmaceutical industry advances towards manufacturing super and complex generics which requires high precision levels of process controls, Good ...